amifostine anhydrous has been researched along with Di Guglielmo Disease in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Preisler, HD | 1 |
Li, B | 1 |
Yang, BL | 1 |
Huang, RW | 1 |
Devemy, E | 1 |
Venugopal, P | 1 |
Tao, M | 1 |
Chopra, H | 1 |
Gregory, SA | 1 |
Adler, S | 1 |
Sivaraman, S | 1 |
Toofanfard, P | 1 |
Jajeh, A | 1 |
Galvez, A | 1 |
Robin, E | 1 |
1 trial available for amifostine anhydrous and Di Guglielmo Disease
Article | Year |
---|---|
Suppression of telomerase activity and cytokine messenger RNA levels in acute myelogenous leukemia cells in vivo in patients by amifostine and interleukin 4.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Bone Marrow Cells; Cytokines; Female; fms-Like Tyrosine | 2000 |